Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

E. Giovannetti, R.J. Honeywell, A.R. Hanauske, C. Tekle, B. Kuenen, J. Sigmond, G. Giaccone, G.J. Peters

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Access to Document

@article{719c60c2e9ff4981b03ca519f54e07c7,

title = "Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)",

author = "E. Giovannetti and R.J. Honeywell and A.R. Hanauske and C. Tekle and B. Kuenen and J. Sigmond and G. Giaccone and G.J. Peters",

year = "2010",

doi = "https://doi.org/10.2174/138945010790031009",

language = "Undefined/Unknown",

volume = "11",

pages = "12--28",

journal = "Current drug targets",

issn = "1389-4501",

publisher = "Bentham Science Publishers B.V.",

number = "1",

}

TY - JOUR

T1 - Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

AU - Giovannetti, E.

AU - Honeywell, R.J.

AU - Hanauske, A.R.

AU - Tekle, C.

AU - Kuenen, B.

AU - Sigmond, J.

AU - Giaccone, G.

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.2174/138945010790031009

DO - https://doi.org/10.2174/138945010790031009

M3 - Article

SN - 1389-4501

VL - 11

SP - 12

EP - 28

JO - Current drug targets

JF - Current drug targets

IS - 1

ER -